Table 3. Average annual health expenditure and confidence interval (95%) per person with any expenditure per expenditure component within each health institution (USD for 2014).
| Total expenditure(A) + (D) + (E) + (F) | Medical consultation(A) = (B) + (C) | General physician consultations (B) | Specialist consultations(C) | Laboratory and other tests(D) | Drugs(E) | Hospitalization(F) = (G) + (H) | General ward hospitalization (G) | ICU(H) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic disease/Health institution | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS | MoH | IMSS |
| Arterial hypertension | 198 (129–268) | 598 (409–786) | 28 (28–28) | 121 (121–121) | 26 (26–26) | 106 (106–106) | 2 (2–2) | 15 (15–15) | 5 (3–7) | 3 (2–4) | 1 (1–1) | 2 (1–2) | 164 (98–230) | 472 (279–664) | 35 (21–50) | 110 (64–155) | 129 (77–181) | 362 (218–506) |
| Gastritis | 69 (44–91) | 198 (131–265) | 16 (16–16) | 96 (96–96) | 15 (15–15) | 81 (81–81) | 1 (1–1) | 15 (15–15) | 2 (1–3) | 2 (1–3) | 1 (1–1) | 1 (1–1) | 50 (26–75) | 99 (33–166) | 50 (26–75) | 99 (33–166) | 0 (0–0) | 0 (0–0) |
| Type 2 diabetes | 184 (106–261) | 691 (447–934) | 26 (26–26) | 160 (160–160) | 25 (25–25) | 125 (125–125) | 1 (1–1) | 35 (35–35) | 12 (6–18) | 7 (4–10) | 1 (1–1) | 1 (1–1) | 145 (60–230) | 522 (247–798) | 45 (20–69) | 173 (87–259) | 100 (46–155) | 349 (172–526) |
| Irritable bowel syndrome | 31 (23–40) | 247 (138–357) | 17 (17–17) | 114 (114–114) | 13 (13–13) | 87 (87–87) | 4 (4–4) | 27 (27–27) | 2 (1–4) | 1 (1–3) | 1 (1–1) | 1 (1–1) | 11 (3–20) | 131 (26–236) | 11 (3–20) | 131 (26–236) | 0 (0–0) | 0 (0–0) |
| Depressive disorder | 81 (42–118) | 570 (252–886) | 26 (26–26) | 176 (176–176) | 9 (9–9) | 91 (91–91) | 17 (17–17) | 85 (85–85) | 1 (1–3) | 1 (1–1) | 4 (1–6) | 5 (2–8) | 50 (13–86) | 388 (70–707) | 50 (13–86) | 388 (70–707) | 0 (0–0) | 0 (0–0) |
| Chronic kidney disease* | 8,966 (8,756–9,174) | 9,091 (8,368–9812) | 35 (35–35) | 301 (301–301) | 28 (28–28) | 41 (41–41) | 7 (7–7) | 260 (260–260) | 19 (5–33) | 19 (7–30) | 1 (1–1) | 1 (1–1) | 365 (162–568) | 1630 (888–2,373) | 365 (162–568) | 1,630 (888–2,373) | 0 (0–0) | 0 (0–0) |
| Osteoarthritis | 103 (51–206) | 354 (56–652) | 24 (24–24) | 110 (110–110) | 13 (13–13) | 65 (65–65) | 11 (11–11) | 45 (45–45) | 2 (1–4) | 7 (2–12) | 2 (1–3) | 2 (1–3) | 75 (27–177) | 235 (46–515) | 75 (27–177) | 235 (46–515) | 0 (0–0) | 0 (0–0) |
| Chronic ischemic heart disease | 440 (211–668) | 2,800 (1756–3847) | 20 (20–20) | 284 (284–284) | 5 (5–5) | 76 (76–76) | 15 (15–15) | 208 (208–208) | 6 (1–13) | 14 (5–23) | 1 (1–2) | 4 (2–6) | 413 (207–618) | 2498 (1454–3543) | 104 (49–159) | 682 (408–957) | 309 (136–482) | 1,816 (1,026–2,606) |
| Asthma | 170 (47–294) | 430 (149–710) | 31 (31–31) | 186 (186–186) | 31 (31–31) | 96 (96–96) | 0 (0–0) | 90 (90–90) | 2 (1–5) | 6 (1–11) | 4 (2–7) | 3 (1–6) | 133 (6–260) | 235 (53–523) | 133 (6–260) | 235 (53–523) | 0 (0–0) | 0 (0–0) |
Source: Own processing based on health care consumption identified by the present study.
Notes:
* = includes expenditure of kidney dialysis (dialysis or hemodialysis), for MoH the expenditure was US$ 8,546 and for IMSS was $7,140; CD = Chronic disease; MoH = Ministry of Health; IMSS = Mexican Institute of Social Security; ICU: Intensive Care Unit.